Kevin Rakin - Aug 9, 2021 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Kevin Rakin
Stock symbol
ORMP
Transactions as of
Aug 9, 2021
Transactions value $
$14
Form type
4
Date filed
8/11/2021, 05:15 PM
Previous filing
Jun 15, 2021
Next filing
Sep 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Options Exercise $35.5K +5.7K +37.83% $6.23 20.8K Aug 9, 2021 Direct
transaction ORMP Common Stock Tax liability -$35.5K -1.68K -8.11% $21.09* 19.1K Aug 9, 2021 Direct F1
transaction ORMP Common Stock Options Exercise $32K +6.67K +34.95% $4.80 25.7K Aug 9, 2021 Direct
transaction ORMP Common Stock Tax liability -$32K -1.52K -5.89% $21.09* 24.2K Aug 9, 2021 Direct F2
transaction ORMP Common Stock Options Exercise $41.7K +10K +41.28% $4.17 34.2K Aug 9, 2021 Direct
transaction ORMP Common Stock Tax liability -$41.7K -1.98K -5.78% $21.09* 32.2K Aug 9, 2021 Direct F3
transaction ORMP Common Stock Options Exercise $441K +56.8K +176.06% $7.77 89K Aug 9, 2021 Direct
transaction ORMP Common Stock Tax liability -$441K -20.9K -23.5% $21.09* 68.1K Aug 9, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORMP Stock Option (right to buy) Options Exercise $0 -5.7K -100% $0.00* 0 Aug 9, 2021 Common Stock 5.7K $6.23 Direct
transaction ORMP Stock Option (right to buy) Options Exercise $0 -6.67K -100% $0.00* 0 Aug 9, 2021 Common Stock 6.67K $4.80 Direct
transaction ORMP Stock Option (right to buy) Options Exercise $0 -10K -100% $0.00* 0 Aug 9, 2021 Common Stock 10K $4.17 Direct
transaction ORMP Stock Option (right to buy) Options Exercise $0 -56.8K -100% $0.00* 0 Aug 9, 2021 Common Stock 56.8K $7.77 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a cashless exercise of outstanding stock options to purchase 5,697 shares of common stock. The reporting person received 4,014 shares of common stock and surrendered 1,683 shares of common stock underlying the stock option in payment of the exercise price.
F2 Represents a cashless exercise of outstanding stock options to purchase 6,666 shares of common stock. The reporting person received 5,149 shares of common stock and surrendered 1,517 shares of common stock underlying the stock option in payment of the exercise price.
F3 Represents a cashless exercise of outstanding stock options to purchase 10,000 shares of common stock. The reporting person received 8,023 shares of common stock and surrendered 1,977 shares of common stock underlying the stock option in payment of the exercise price.
F4 Represents a cashless exercise of outstanding stock options to purchase 56,773 shares of common stock. The reporting person received 35,857 shares of common stock and surrendered 20,916 shares of common stock underlying the stock option in payment of the exercise price.
F5 The options vested as follows: 15,591 vested on December 31, 2017, 2018 and 2019 and additional 10,000 vested on December 31, 2020.